Download the Agenda and application details (pdf)
TRAINING COURSE
SEVERE CONGENITAL NEUTROPENIA – A CLINICAL APPROACH
24-25 MARCH 2021
Virtual event via ZOOM platform
https://us02web.zoom.us/j/7781623506
TIME ZONE: GMT+2 ( in Israeli local time)
Local Organizers
Hannah Tamary and Orna Steinberg-Shemer
Schneider Children's Medical Center of Israel, Hematology/Oncology Division,
Petach Tikva, Israel
Watch the Training School here! (Members Area)
March 24th, 2021
15:00-15:20 Diagnostic workup of neonates and children with neutropenia
Dr Joanne Yacobovich
15:20-15:30 Q &A
15:30-15:50 Genetic methods for the diagnosis of congenital neutropenia
Dr Orly Dgany
15:50-16:00 Q & A
16:00-16:20 Treatment and follow-up of patients with congenital neutropenia
Dr Orna Steinberg-Shemer
16:20-16:30 Q & A
16:30-16:50 Congenital neutropenia in adults
Dr Helen Papadaki
16:50-17:00 Q & A
March 25th, 2021
15:00-15:20 Summary of patients with congenital neutropenia registered in the European SCNIR
Dr Connie Zeidler
15:20-15:30 Q & A
15:30-15:50 The molecular basis of congenital neutropenia in a nutshell
Dr Julia Skokowa
15:50-16:00 Q & A
16:00-17:00 Case presentations from the participants. Expert panel
Drs Hannah Tamary, Joanne Yacobovich, Orly Dgany, Orna Steinberg-Shemer, Julia Skokowa, Karl Welte, Connie Zeidler, Helen Papadaki
Contact Information:
Please, send your application accompanied by a short letter of motivation via e-mail to Dr Hannah Tamary This email address is being protected from spambots. You need JavaScript enabled to view it. and Dr Orna Steinberg Shemer This email address is being protected from spambots. You need JavaScript enabled to view it. with cc to EuNet-INNOCHRON coordinator This email address is being protected from spambots. You need JavaScript enabled to view it., by March 19, 2021.
Should you be interested to present your case, please send two slides, with your name/affiliation in the first slide and the key points of your case presentation in the second one, to the above e-mail addresses, by March 19, 2021.